PEAK6’s Labcorp LH Stock Holding History

PEAK6’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2	Closed	-$531	–	3134
2025 Q3	$672	Sell	2 -1	-33%	-$268	﹤0.01%	2834
2025 Q2	$756	Buy	+3	New	+$731	﹤0.01%	2859

Other funds holding LH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

PEAK6's LH Position: Q4 2025 in Review

PEAK6 sold out of Labcorp (LH) in Q4 2025, closing a stake of 2 shares — an estimated $531 sold.

PEAK6 first reported a position in LH in Q2 2025 and held it in 2 quarters. The position peaked at $756 in Q2 2025. 1,029 funds tracked by Wall St. Rank hold LH as of Q4 2025.

PEAK6 reported no remaining Labcorp position as of Q4 2025 after selling out during the quarter.
PEAK6 sold 2 Labcorp shares in Q4 2025, an estimated $531.
PEAK6 first reported a position in Labcorp in Q2 2025 and held it in 2 quarters.
PEAK6's Labcorp position peaked at $756 in Q2 2025.
1,029 funds tracked by Wall St. Rank held Labcorp as of Q4 2025.

Based on PEAK6's 13F filing for Q4 2025, filed 13 Feb 2026.